Phase 1 Squamous Cell Carcinoma (SCC) Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)

Head and NeckHNSCCSquamous Cell Cancer of Head and Neck (SCCHN)+8 more

Vanderbilt-Ingram Cancer Center40 enrolled1 locationNCT07460765

Recruiting

Phase 1

Phase 1 Clinical Trial of FluBHPVE6E7 Immunotherapy for HPV16-Associated Oropharyngeal Cancer

Oropharyngeal Squamous Cell Carcinoma (SCC)

BlueSky Immunotherapies GmbH12 enrolled1 locationNCT06589609